# Gentex Corp: Form 10-Q for the period ended Mar 31, 2024

- Company: [Gentex Corp](/companies/gntx.md) (CIK 355811)
- Form: 10-Q
- Filed: 2024-05-03
- Accepted by EDGAR: May 3, 2024, 10:17 ET
- Period: 2024-03-31
- Accession: 0000355811-24-000027
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/355811/000035581124000027/gntx-20240331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/355811/000035581124000027/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-01-01 to 2024-03-31 | $590.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2024-01-01 to 2024-03-31 | $388.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2024-01-01 to 2024-03-31 | $202.2m | us-gaap:GrossProfit |
| Research and development | 3 months, 2024-01-01 to 2024-03-31 | $42.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2024-01-01 to 2024-03-31 | $30.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2024-01-01 to 2024-03-31 | $129.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2024-01-01 to 2024-03-31 | $19.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-01-01 to 2024-03-31 | $108.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-01-01 to 2024-03-31 | $0.47 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-01-01 to 2024-03-31 | $0.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-01-01 to 2024-03-31 | 228,408,138 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2024-01-01 to 2024-03-31 | $129.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2024-01-01 to 2024-03-31 | $31.9m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months, 2024-01-01 to 2024-03-31 | $27.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2024-01-01 to 2024-03-31 | $41.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2024-03-31 | $249.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-03-31 | $1.07bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-03-31 | $2.71bn | us-gaap:Assets |
| Current liabilities | at 2024-03-31 | $304.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-03-31 | $336.9m | us-gaap:Liabilities |
| Shareholders' equity | at 2024-03-31 | $2.38bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/355811/000035581124000027/gntx-20240331.htm

Filed May 3, 2024.
Source: SEC EDGAR, the filing index for accession 0000355811-24-000027. Last ingested by Listed: Nov 6, 2026, 14:07 ET. No prices; not investment advice.